Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-05

Clinical Trial Update: Clinical Study to Investigate the Antihypersensitivity Efficacy of a Novel Dentifrice [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the antihypersensitivity efficacy of a novel dentifrice; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Novel Dentifrice

Snippet

Sponsor: HALEON | Conditions: Dentin Hypersensitivity | Phase 3 | Status: RECRUITING